# Precision Biopsy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/precision-biopsy

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.precisionbiopsy.com
- Total disclosed funding: $36M
- Latest round: Series B (Oct 5, 2015)
- Investors on record: 2

## About

Precision Biopsy specializes in advanced biopsy solutions, focusing on enhancing the accuracy and safety of diagnostic procedures using innovative technologies.Founded in 2008 in Boston, US, Precision Biopsy is dedicated to developing cutting-edge imaging and biopsy technologies. The company has successfully raised funding, with the most recent deal being a Series B round in October 2015, where it secured USD 33.6 mn led by Woodford Patient Capital Trust and supported by Allied Minds. The total amount raised to date is USD 33.6 mn, with a current valuation of USD 90.4 mn.Precision Biopsy provides state-of-the-art biopsy technologies aimed at improving diagnostic precision. Their products include advanced imaging systems that facilitate targeted biopsies, thereby enhancing patient safety and diagnostic outcomes, crucial for conditions such as prostate cancer.Precision Biopsy generates revenue primarily through the sale of its innovative biopsy devices and technologies to healthcare providers and institutions. This revenue model is bolstered by ongoing partnerships and collaborations within the medical community, leading to sustained demand for its products.Following the Series B funding in October 2015, Precision Biopsy plans to utilize the raised capital to support the development of new biopsy technologies and expand its product offerings. The company is also targeting international markets for expansion, with plans to enter Europe and Asia by 2025, aiming to broaden its customer base and enhance its global footprint.

## Funding rounds

- Series B, Oct 5, 2015, $34M — Allied Minds, Woodford Patient Capital Trust
- Series A, Jul 6, 2011, $2.5M — Allied Minds

## Investors

- Allied Minds (https://capitalatlas.ai/funds/allied-minds) — Series A, Series B
- Woodford Patient Capital Trust — Series B